Nektar Therapeutics (NKTR) Presents At 34th Annual Meeting of SITC -

NEKTAR® NEW PATHWAYS TO SMARTER MEDICINE™ SITC 2019 Nektar Therapeutics Investor & Analyst Call November 10, 2019 This presentation includes forward-looking statements regarding Nektar's proprietary drug candidates, the timing of the start and conclusion of ongoing or planned clinical trials, the timing and outcome of regulatory decisions, and future availability of clinical trial data. Actual results could differ materially and these statements are subject to important risks detailed in Nektar's filings wi ...